Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Humana Inc (HUM) vs T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) Price & Performance

Humana IncTrade
T-Rex 2X Inverse MSTR Daily Target ETFTrade

Price performance (Past 24H)

Key statistics

Humana Inc vs T-Rex 2X Inverse MSTR Daily Target ETF — how do they compare? Humana Inc trades at $435.34 (market cap $46.49B), while T-Rex 2X Inverse MSTR Daily Target ETF trades at $2.56 (market cap $94.46M). The key difference: Humana Inc is far larger — about 492.2× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and Humana Inc pays a 0.91% dividend while T-Rex 2X Inverse MSTR Daily Target ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days on average.

HUMMSTZ
Market Cap
$46.49B$94.46M
Volume
2,567,704104,717,733
Sector
HealthLeveraged / Inverse
52-Week High
$409.85$27.92
52-Week Low
$163.67$2.29
Typical Hold Time
53 Days8 Days
Enterprise Value
$53.84B—
Dividend Yield
0.91%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Humana Inc

Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.

The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.

T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ is trading at $2.54, down 4.51% today, with technical indicators showing a bearish trend as moving averages signal selling pressure. The stock lacks key financial ratio data, making fundamental assessment challenging. Recent ETF coverage highlights its inclusion in leveraged/inverse ETF discussions, though specific company performance details are limited.

The outlook remains cautious due to incomplete financial disclosures and bearish technical signals. Investment opportunities depend on forthcoming earnings clarity, while risks include volatility from limited institutional coverage and market sentiment shifts. Investors should await detailed financial updates for informed decisions.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HUM

No sentiment data available yet.

MSTZ
47% Buy53% Sell
Avg holding period · 8 Days

Top news

Latest headlines on both assets

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM →

About T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.

Read more on MSTZ →